Aytu BioPharma, Inc.: Aytu BioPharma Announces the Appointment of Vivian Liu to the Company's Board of Directors

ENGLEWOOD, CO / ACCESSWIRE / June 29, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the appointment of

Related Keywords

University Of Southern California ,California ,United States ,Englewood ,Berkeley ,Aytu Biopharma ,Mark Oki ,Vivian Liu ,Apricus Biosciences ,Josh Disbrow ,University Of California ,Fastrack Pharmaceuticals Inc ,Nasdaq ,Innovus Pharmaceuticals Inc ,Audit Committee For Thermogenesis Holdings Inc ,Corporate Governance Committee ,Cesca Therapeutics Inc ,Drug Administration ,European Commission ,Oxonc Services Company ,Nexmed Inc ,Exchange Commission ,Head Of Corporate Affairs ,Aytu Biopharma Inc ,Securities Exchange ,Corporate Affairs ,Corporate Governance ,Chief Executive Officer ,Chief Financial Officer ,Innovus Pharmaceuticals ,Fastrack Pharmaceuticals ,Audit Committee ,Thermogenesis Holdings Inc ,Chief Operating Officer ,Cesca Therapeutics ,Managing Director ,Executive Vice President ,Vice President ,Southern California ,Full Prescribing Information ,Vascular Ehlers Danlos Syndrome ,Orphan Drug ,Fast Track ,Securities Act ,Securities Exchange Act ,Risk Factor ,Quarterly Reports ,Chief Financial ,Aytu ,Iopharma ,Nnounces ,Appointment ,Ivian ,Company ,Board ,Directors ,